TY  - CHAP
AU  - Laura Antolino
AU  - Paolo Aurello
AU  - Federico Todde
AU  - Silvia Amato
AU  - 
Niccolò Petrucciani
AU  - Andrea Kazemi Nava
AU  - Giuseppe Nigri
AU  - Stefano
Valabrega
AU  - Giovanni Ramacciato
AU  - Francesco D’Angelo
ED  - Luis Rodrigo
Y1  - 2018-09-05
PY  - 2018
T1  - The Role of Neoadjuvant Therapy in Surgical Treatment of Pancreatic Cancer
N2  - Pancreatic cancer is a growing source of cancer-related death and has poor survival rates, which have not improved in the last few decades. Its high-mortality rate is attributed to pancreatic cancer biology, difficulty in early diagnosis, and lack of standardized international guidelines in assessing the pancreatic masses. This book aims to provide an update in the current state of play in pancreatic cancer diagnosis and to evaluate the benefits and limitations of the available diagnostic technology and therapy. The main modalities for diagnosis are imaging with HCT, MRI, USE, and PET. Some chapters review the improvements in the techniques used. Timely and accurate diagnosis of pancreatic cancer can lead to improve in the current poor outcome of this disease.
BT  - Advances in Pancreatic Cancer
SP  - Ch. 10
UR  - https://doi.org/10.5772/intechopen.76750
DO  - 10.5772/intechopen.76750
SN  - 978-1-78923-641-5
PB  - IntechOpen
CY  - Rijeka
Y2  - 2024-04-25
ER  -